ARK Invest Buys Tesla Shares Amid Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy TSLA?
Source: seekingalpha
- Significant Purchases: ARK Invest acquired nearly 81,000 shares of Tesla over three days during the stock's decline, investing over $28 million, demonstrating ongoing confidence in the electric vehicle market despite volatility.
- Holding Proportion: As of Wednesday, Tesla constituted 8.49% of ARKK ETF's portfolio, remaining its largest holding, even as the stock has fallen 13.9% this month and approximately 24% year-to-date.
- Divergent Analyst Opinions: Despite mixed market sentiment and a cautious Underweight rating from JPMorgan, which flagged rising inventory risks, ARK continues to emphasize autonomous driving as a key component of its long-term investment thesis.
- Weak Market Sentiment: Tesla's stock hit a 2026 low on Tuesday, reflecting ongoing weakness in sentiment towards electric vehicles, battery storage, and AI stocks, as investors remain cautious ahead of the upcoming Q1 earnings report.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TSLA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TSLA
Wall Street analysts forecast TSLA stock price to rise
30 Analyst Rating
12 Buy
11 Hold
7 Sell
Hold
Current: 346.650
Low
25.28
Averages
401.93
High
600.00
Current: 346.650
Low
25.28
Averages
401.93
High
600.00
About TSLA
Tesla, Inc. designs, develops, manufactures, sells and leases high-performance fully electric vehicles and energy generation and storage systems, and offers services related to its products. Its segments include automotive, and energy generation and storage. The automotive segment includes the design, development, manufacturing, sales and leasing of high-performance fully electric vehicles, and sales of automotive regulatory credits. It also includes sales of used vehicles, non-warranty maintenance services and collisions, part sales, paid supercharging, insurance services revenue and retail merchandise sales. The energy generation and storage segment include the design, manufacture, installation, sales and leasing of solar energy generation and energy storage products and related services and sales of solar energy systems incentives. Its consumer vehicles include the Model 3, Y, S, X and Cybertruck. Its lithium-ion battery energy storage products include Powerwall and Megapack.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tesla's Q1 Deliveries Fall Short of Expectations
- Delivery and Production Gap: Tesla delivered 358,023 vehicles in Q1, missing the analyst expectation of 370,000 units and marking a 14.4% drop from 418,227 units in the previous quarter, indicating weak demand in the EV market that could hinder future sales growth.
- Inventory Build-Up Issue: The company produced over 408,000 vehicles in Q1, exceeding deliveries by about 50,000 units, which raises concerns about liquidity and may impact Tesla's ability to invest in capital-intensive projects.
- Decline in Energy Storage Business: Energy storage deployments plummeted 38% to 8.8 GWh in Q1, down from 14.2 GWh in the prior quarter, weakening a critical pillar of support for the company's overall growth narrative and potentially affecting investor confidence.
- Capital Expenditure Pressure: Tesla forecasts capital expenditures to exceed $20 billion this year; while the company is making significant investments in AI and robotics, the weak demand in its core automotive business could lead to insufficient future cash flow, increasing financial risk.
See More
ARK Invest Increases Tesla Holdings Amid Stock Pullback
- Increased Tesla Holdings: ARK Invest purchased 79,845 shares of Tesla this week for approximately $27.8 million, demonstrating confidence during the stock's pullback, even as Tesla's shares hit a seven-month low, negatively impacting ARKK's overall performance.
- Production Plan Shift: CEO Elon Musk announced that only a few hundred Model S and Model X vehicles remain in inventory, with plans to cease production of these models next quarter and repurpose the Fremont factory for the Optimus humanoid robot, marking a significant strategic shift for the company.
- Delivery Data Insights: Tesla delivered about 16,130 vehicles in the “other models” category in Q1, while Model 3 and Model Y deliveries totaled 341,893, indicating strong performance in high-demand models, yet the overall delivery figures could not offset the stock price decline.
- Market Sentiment and Risks: While ARK continues to accumulate shares, JPMorgan reiterated its 'Underweight' rating, warning of a potential 60% downside for the stock and lowering its 2026 EPS forecast to $1.8, reflecting uncertainties around demand and inventory levels.
See More
Intel's Terafab Project Partnership Sparks Analyst Caution
- Analyst Caution: Following Intel's announcement of its partnership with the Terafab AI chip project, some analysts have adopted a more cautious stance, suggesting that the stock's recent rally may not accurately reflect the company's fundamentals.
- Strategic Partnership Impact: While the collaboration with Terafab is seen as strategically intriguing, analysts emphasize that it does not significantly alleviate Intel's current short-term challenges, prompting investors to seek tangible improvements in sales and margins.
- Market Reaction Analysis: Intel's stock has garnered attention due to its association with Tesla, SpaceX, and xAI, yet analysts argue that the price increase is not entirely supported by the company's operational performance, necessitating further evidence to validate its long-term value.
- Uncertain Future Outlook: Although the Terafab initiative could potentially strengthen Intel's position in advanced manufacturing, analysts remain cautious about the lack of clear evidence regarding its financial impact, anticipating that future developments will significantly influence stock price movements.
See More
Pharmaceutical Industry Automation Transformation Accelerates
- Regulatory Upgrades: The EU's updated GMP Annex 1 emphasizes minimizing human involvement and implementing comprehensive contamination control strategies, requiring manufacturers to assess and mitigate risks across personnel, processes, and environments, thus driving the pharmaceutical industry towards higher compliance standards.
- Intelligent Robotics Application: Nightfood Holdings is advancing AI-driven robotic platforms through TechForce Robotics, combining autonomous functionality with SOP intelligence and real-time deviation detection, aimed at enhancing compliance and operational efficiency in the pharmaceutical sector, reflecting the growing demand for intelligent systems in the industry.
- Persistent Contamination Risks: Despite technological advancements, FDA inspection findings indicate that deficiencies in contamination control and data integrity remain widespread, suggesting that traditional automation approaches have not fully addressed these issues, impacting drug supply chains and patient access to critical medications.
- Market Opportunities Emerge: The pharmaceutical manufacturing sector has been relatively slow to adopt automation, presenting significant market opportunities for technological advancement; Nightfood Holdings' strategic collaboration with Oncotelic Therapeutics aims to develop a GMP-compliant robotics platform, driving the industry's digital transformation.
See More
Tesla Developing New Compact SUV at Lower Price Point
- New Model Development: Tesla is reportedly developing a new compact SUV that is expected to be priced significantly lower than the Model 3, which could attract more budget-conscious consumers and expand its market share.
- Supplier Engagement: According to a Reuters report, Tesla has reached out to suppliers in recent weeks to discuss the manufacturing process and specifications for the compact SUV, indicating the company's commitment and preparation for the new model.
- Market Reaction: While Tesla shares edged up 0.1% in Thursday's pre-market trading, retail sentiment on Stocktwits trended bearish, reflecting a cautious market outlook regarding the new vehicle.
- Industry Implications: Tesla's compact SUV initiative could impact the entire electric vehicle market, particularly among price-sensitive consumer segments, intensifying competition and driving innovation within the industry.
See More
Tesla Developing Lower-Cost Compact Electric SUV
- New Model Development: Tesla is developing a smaller, lower-cost electric SUV, and while the project is still in its early stages, the company has begun discussions with suppliers regarding manufacturing processes and component specifications, indicating its intent to explore new market segments.
- Market Positioning: The SUV is expected to be shorter than the Model Y and priced significantly lower than the Model 3, which starts at $34,000 in China, aiming to attract a broader consumer base, with initial production likely in China before expanding to the U.S. and Europe.
- Strategic Shift: This move follows CEO Elon Musk's decision to scrap plans for a low-cost EV in 2024 and pivot towards robotaxis and humanoid robots, showcasing the company's adaptability in the electric vehicle market.
- Future Outlook: While it remains unclear if this SUV signifies a return to mass-market vehicles, sources suggest the new model could cater to both human-driven and autonomous driving functionalities, reflecting Tesla's long-term vision for autonomous technology.
See More
Tesla's Q1 Deliveries Fall Short of Expectations
- Delivery and Production Gap: Tesla delivered 358,023 vehicles in Q1, missing the analyst expectation of 370,000 units and marking a 14.4% drop from 418,227 units in the previous quarter, indicating weak demand in the EV market that could hinder future sales growth.
- Inventory Build-Up Issue: The company produced over 408,000 vehicles in Q1, exceeding deliveries by about 50,000 units, which raises concerns about liquidity and may impact Tesla's ability to invest in capital-intensive projects.
- Decline in Energy Storage Business: Energy storage deployments plummeted 38% to 8.8 GWh in Q1, down from 14.2 GWh in the prior quarter, weakening a critical pillar of support for the company's overall growth narrative and potentially affecting investor confidence.
- Capital Expenditure Pressure: Tesla forecasts capital expenditures to exceed $20 billion this year; while the company is making significant investments in AI and robotics, the weak demand in its core automotive business could lead to insufficient future cash flow, increasing financial risk.
See More
ARK Invest Increases Tesla Holdings Amid Stock Pullback
- Increased Tesla Holdings: ARK Invest purchased 79,845 shares of Tesla this week for approximately $27.8 million, demonstrating confidence during the stock's pullback, even as Tesla's shares hit a seven-month low, negatively impacting ARKK's overall performance.
- Production Plan Shift: CEO Elon Musk announced that only a few hundred Model S and Model X vehicles remain in inventory, with plans to cease production of these models next quarter and repurpose the Fremont factory for the Optimus humanoid robot, marking a significant strategic shift for the company.
- Delivery Data Insights: Tesla delivered about 16,130 vehicles in the “other models” category in Q1, while Model 3 and Model Y deliveries totaled 341,893, indicating strong performance in high-demand models, yet the overall delivery figures could not offset the stock price decline.
- Market Sentiment and Risks: While ARK continues to accumulate shares, JPMorgan reiterated its 'Underweight' rating, warning of a potential 60% downside for the stock and lowering its 2026 EPS forecast to $1.8, reflecting uncertainties around demand and inventory levels.
See More
Intel's Terafab Project Partnership Sparks Analyst Caution
- Analyst Caution: Following Intel's announcement of its partnership with the Terafab AI chip project, some analysts have adopted a more cautious stance, suggesting that the stock's recent rally may not accurately reflect the company's fundamentals.
- Strategic Partnership Impact: While the collaboration with Terafab is seen as strategically intriguing, analysts emphasize that it does not significantly alleviate Intel's current short-term challenges, prompting investors to seek tangible improvements in sales and margins.
- Market Reaction Analysis: Intel's stock has garnered attention due to its association with Tesla, SpaceX, and xAI, yet analysts argue that the price increase is not entirely supported by the company's operational performance, necessitating further evidence to validate its long-term value.
- Uncertain Future Outlook: Although the Terafab initiative could potentially strengthen Intel's position in advanced manufacturing, analysts remain cautious about the lack of clear evidence regarding its financial impact, anticipating that future developments will significantly influence stock price movements.
See More
Pharmaceutical Industry Automation Transformation Accelerates
- Regulatory Upgrades: The EU's updated GMP Annex 1 emphasizes minimizing human involvement and implementing comprehensive contamination control strategies, requiring manufacturers to assess and mitigate risks across personnel, processes, and environments, thus driving the pharmaceutical industry towards higher compliance standards.
- Intelligent Robotics Application: Nightfood Holdings is advancing AI-driven robotic platforms through TechForce Robotics, combining autonomous functionality with SOP intelligence and real-time deviation detection, aimed at enhancing compliance and operational efficiency in the pharmaceutical sector, reflecting the growing demand for intelligent systems in the industry.
- Persistent Contamination Risks: Despite technological advancements, FDA inspection findings indicate that deficiencies in contamination control and data integrity remain widespread, suggesting that traditional automation approaches have not fully addressed these issues, impacting drug supply chains and patient access to critical medications.
- Market Opportunities Emerge: The pharmaceutical manufacturing sector has been relatively slow to adopt automation, presenting significant market opportunities for technological advancement; Nightfood Holdings' strategic collaboration with Oncotelic Therapeutics aims to develop a GMP-compliant robotics platform, driving the industry's digital transformation.
See More
Tesla Developing New Compact SUV at Lower Price Point
- New Model Development: Tesla is reportedly developing a new compact SUV that is expected to be priced significantly lower than the Model 3, which could attract more budget-conscious consumers and expand its market share.
- Supplier Engagement: According to a Reuters report, Tesla has reached out to suppliers in recent weeks to discuss the manufacturing process and specifications for the compact SUV, indicating the company's commitment and preparation for the new model.
- Market Reaction: While Tesla shares edged up 0.1% in Thursday's pre-market trading, retail sentiment on Stocktwits trended bearish, reflecting a cautious market outlook regarding the new vehicle.
- Industry Implications: Tesla's compact SUV initiative could impact the entire electric vehicle market, particularly among price-sensitive consumer segments, intensifying competition and driving innovation within the industry.
See More
Tesla Developing Lower-Cost Compact Electric SUV
- New Model Development: Tesla is developing a smaller, lower-cost electric SUV, and while the project is still in its early stages, the company has begun discussions with suppliers regarding manufacturing processes and component specifications, indicating its intent to explore new market segments.
- Market Positioning: The SUV is expected to be shorter than the Model Y and priced significantly lower than the Model 3, which starts at $34,000 in China, aiming to attract a broader consumer base, with initial production likely in China before expanding to the U.S. and Europe.
- Strategic Shift: This move follows CEO Elon Musk's decision to scrap plans for a low-cost EV in 2024 and pivot towards robotaxis and humanoid robots, showcasing the company's adaptability in the electric vehicle market.
- Future Outlook: While it remains unclear if this SUV signifies a return to mass-market vehicles, sources suggest the new model could cater to both human-driven and autonomous driving functionalities, reflecting Tesla's long-term vision for autonomous technology.
See More
